The effects of antisense oligonucleotides bcl-2/bcl-xl and bcl-2 on proliferation and apoptosis of breast cancer cells

Journal of Sichuan University (Medical Science)

Volumn 40, Issue 5, 2009, Pages 780-783

  Ma, Chao ^a   Xie, Jia Wei ^a   Kuang, An Ren ^a   Huang, Rui ^a   Tang, Gong Shun ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Antisense therapy; Bcl 2 gene; Bcl xl gene; Breast cancer cells

Indexed keywords

EID: 70349750370     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Fenske DB, MacLachlan I. Cullis PR. Long-circulating vectors for the systemic delivery of genes. Curr Opin Mol Ther,2001,13 (2), 153-158.
2. Song LY, Ahkong QF, Rong Q, et al. Characterization of the inhibitory effect of PEG-lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes. Biochim Biophys Acta,2002,11558(1) 1-13.
3. chainges language
4. chainges language
5. chainges language
6. Moreno A, Figueras A, Lloveras B,et al. Apoptosis in ductal carcinoma in situ of the breast. Breast J,2001,7(4) ,245-248.
7. Chi KC, Wallis AE, Lee CH, et al. Effects of Bcl-2 modulation with G3139 antisense oligonucleotide on human breast cancer cells are independent of inherent Bcl-2 protein expression. Breast Cancer Res Treat,2000,63(3) ,199-212.
8. Simoes-Wust AP, Olie RA, Gautschi O, et al. Bcl-xl antisense treatment induces apoptosis in breast carcinoma cells. Int J Cancer,2000,87(4),582-590.
9. Akhtar S, Hughes MD, Khan A, et al. The delivery of antisense therapeutics. Adv Drug Deliv Rev,2000,44(1) ,3-21.
10. Juliano R, Alam MR, Dixit V, et al. Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides. Nucleic Acids Res,2008,36(12) ,4158-4171.
11. Zelphati O, Szoka FC Jr. Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipids. Pharm Res, 1996,13(90) ,1367-1372.
12. Gautschi O, Tschopp S, Olie RA, et al. Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins. J Natl Cancer Inst, 2001,93(6) , 463-471.
13. Nicholas AR, Scott MJ, Kennedy NI, et al. Effect of grafted polyethylene glycol (PEG) on the size, encapsulation efficiency and permeability of vesicles. Biochim Biophys Acta,2000,1463 (1), 167-178.
14. chainges language
15. Tamm I, Dorken B, Hartmann G. Antisense therapy in oncology, new hope for an old idea? Lancet,2001,358(9280) , 489-497.
16. Loke SL, Stein C, Zhang X, et al. Delivery of c-myc antisense phosphorothioate oligodeoxynucleotides to hematopoietic cells in culture by liposome fusion, specific reduction in c-myc protein expression correlates with inhibition of cell growth and DNA synthesis. Curr Top Microbiol Immunol, 1988,141,282-289.
17. Thierry AR, Rahman A, Dritschilo A. Overcoming multidrug resistance in human tumor celts using free and liposomally encapsulated antisense oligodeoxynucleotides. Biochem Biophys Res Commun, 1993,190(3) ,952-960.
18. Ross PC, Hui SW. Polyethylene glycol enhances lipoplex-cell association and lipofection. Biochim Biophys Acta, 1999; 1421(2) ,273-283.